Caption Management, LLC Cara Therapeutics, Inc. Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $259,312 - $481,728	34,807 Added 490.24%	41,907 $383,000
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $1.09 Million - $2.58 Million	-88,310 Reduced 92.56%	7,100 $101,000
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $1.44 Million - $2.07 Million	95,410 New	95,410 $2.07 Million
Q2 2020 Aug 14, 2020	SELL	$12.39 - $17.33 $859,804 - $1.2 Million	-69,395 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $118,514 - $231,051	12,995 Added 23.04%	69,395 $916,000
Q4 2019 Feb 13, 2020	BUY	$16.11 - $25.98 $2,416 - $3,897	150 Added 0.27%	56,400 $909,000
Q1 2019 May 14, 2019	BUY	$14.41 - $19.64 $810,562 - $1.1 Million	56,250 New	56,250 $1.1 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.